Loading viewer...
report
Format: PDF report
This report evaluates the clinical efficacy of ONC201 in treating non-midline H3 K27M-mutant diffuse gliomas, highlighting its potential as a therapeutic option.
Saab
report
1st Source Corporation
report
Ondas Holdings
report
General Motors